CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 80 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $871,000 | -6.5% | 72,200 | -2.8% | 0.01% | -23.1% |
| Q4 2018 | $932,000 | +144.6% | 74,300 | +189.1% | 0.01% | +225.0% |
| Q3 2018 | $381,000 | -8.4% | 25,700 | +4.0% | 0.00% | -20.0% |
| Q2 2018 | $416,000 | +99.0% | 24,700 | +64.7% | 0.01% | +66.7% |
| Q2 2017 | $209,000 | -76.1% | 15,000 | -70.8% | 0.00% | -72.7% |
| Q1 2017 | $875,000 | +375.5% | 51,300 | +186.6% | 0.01% | +266.7% |
| Q4 2016 | $184,000 | +7.6% | 17,900 | +5.9% | 0.00% | +50.0% |
| Q3 2016 | $171,000 | – | 16,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,932,123 | $44,246,000 | 4.48% |
| Ghost Tree Capital, LLC | 350,000 | $8,015,000 | 1.62% |
| INGALLS & SNYDER LLC | 1,322,062 | $30,275,000 | 1.48% |
| SENZAR ASSET MANAGEMENT, LLC | 199,139 | $4,561,000 | 1.44% |
| Matarin Capital Management, LLC | 285,450 | $6,536,805,000 | 0.49% |
| KNOTT DAVID M | 49,557 | $1,135,000 | 0.47% |
| Spark Investment Management LLC | 144,600 | $3,311,000 | 0.21% |
| PRINCETON CAPITAL MANAGEMENT LLC | 16,582 | $380,000 | 0.17% |
| TIVERTON ASSET MANAGEMENT LLC | 77,782 | $1,781,000 | 0.12% |
| CADENCE CAPITAL MANAGEMENT LLC | 82,240 | $1,883,000 | 0.12% |